门德尔对冠状动脉疾病的随机化研究:系统性审查和元分析
Sarah Silva1,2, Segun Fatumo3,4, Dorothea Nitsch5
1Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. Sarah.Silva@lshtm.ac.uk.
Systematic reviews
|January 15, 2024
概括
冠状动脉疾病 (CAD) 的因果风险因素在祖先之间显示了类似的因果关系方向. 然而,这些关系的强度各不相同,这凸显了CAD研究中需要多样化的人口数据的必要性.
科学领域:
- 心血管疾病流行病学
- 遗传学和基因组学 遗传学和基因组学
- 公共卫生 公共卫生
背景情况:
- 冠状动脉疾病 (CAD) 是全球主要的死亡原因.
- 了解可修改的CAD风险因素对于预防至关重要.
- 这项研究侧重于不同祖先群体的因果风险因素.
结论:
- 可修改的风险因素和CAD之间的因果关系在不同祖先的方向上没有差异.
- 观察到的关系强度的差异强调了包括非欧洲人口的重要性.
- 增加全球代表性可能会揭示CAD的新型遗传途径.
更多相关视频
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
428
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
3.9K
相关概念视频
Randomized Experiments
7.0K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
7.0K
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
518
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
518
